Elantan LA 50 mg Prolonged Release Capsules, hard * Pharmacy Only: Prescription
Company:
MERUS LabsStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 30 March 2023
File name
6425a079694aa.pdf
Reasons for updating
- Change to section 6 - date of revision
- Change to date of revision
Updated on 12 January 2023
File name
63c002b19e6be.pdf
Reasons for updating
- Change to section 2 - Qualitative and quantitative composition
- Change to section 4.1 - Therapeutic indications
- Change to section 4.8 - Undesirable effects
- Change to section 6.5 - Nature and contents of container
- Change to section 7 - Marketing authorisation holder
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 12 January 2023
File name
63c00269bbc43.pdf
Reasons for updating
- Change to section 6 - marketing authorisation holder
- Change to section 6 - date of revision
Updated on 30 August 2022
File name
630e2edd156bb.pdf
Reasons for updating
- Change to section 4 - how to report a side effect
- Change to section 6 - date of revision
Updated on 30 August 2022
File name
630e2d3c87ae3.pdf
Reasons for updating
- Change to Section 4.8 – Undesirable effects - how to report a side effect
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 25 November 2019
File name
ie-smpc-ela-en_1574692115.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 25 November 2019
File name
ie-pil-ela-en_1574692020.pdf
Reasons for updating
- New PIL for new product